Envestnet Asset Management
CAPR icon

Envestnet Asset Management’s Capricor Therapeutics CAPR Stock Holding History

Envestnet Asset Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$700K Sell
29,058
-258
-0.9% -$7.82K ﹤0.01% 3854
2026
Q1 		$891K Buy
29,316
+1,912
+7% +$50.9K ﹤0.01% 3533
2025
Q4 		$791K Buy
27,404
+13,662
+99% +$178K ﹤0.01% 3401
2025
Q3 		$99.1K Buy
+13,742
New +$101K ﹤0.01% 4424
2025
Q2 		– Sell
-12,048
Closed -$114K – 4444
2025
Q1 		$114K Buy
+12,048
New +$167K ﹤0.01% 4219

Other funds holding CAPR

MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BDF
Black Diamond Financial Towson, Maryland $1.13B AUM 22.3% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
NC
nVerses Capital Wellington, Florida $65M AUM

Envestnet Asset Management's CAPR Position: Q2 2026 in Review

Envestnet Asset Management reduced its Capricor Therapeutics (CAPR) stake by 0.88% in Q2 2026, selling an estimated $7.82K and leaving 29,058 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #3854.

Envestnet Asset Management first reported a position in CAPR in Q1 2025 and has held it in 5 quarters since. The position peaked at $891K in Q1 2026. 28 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Envestnet Asset Management held 29,058 shares of Capricor Therapeutics worth $700K as of Q2 2026.
  • Envestnet Asset Management sold 258 Capricor Therapeutics shares in Q2 2026, an estimated $7.82K.
  • Capricor Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3854 holding.
  • Envestnet Asset Management first reported a position in Capricor Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Envestnet Asset Management's Capricor Therapeutics position peaked at $891K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.